Document Detail


Angiotensin receptor blocker improves coronary flow velocity reserve in hypertensive patients: comparison with calcium channel blocker.
MedLine Citation:
PMID:  17917317     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Large-scale clinical studies have indicated that angiotensin receptor blockers (ARBs) have beneficial effects against cardiovascular diseases. We designed this study to compare the effects of an ARB and a calcium channel blocker (CCB) on coronary flow velocity reserve (CFVR), a predictor of cardiovascular events, as estimated using transthoracic Doppler echocardiography. Sixteen hypertensive patients (63.1+/-9.6 years old; 10 males) were randomly allocated in a double-blind fashion to valsartan (n=8, 40-80 mg/day) or nifedipine (n=8, 20-40 mg/day) groups. Age- and gender-matched subjects without hypertension were enrolled as a control group (n=12). CFVR was calculated by dividing the adenosine triphosphate-induced hyperemic flow velocity by the basal flow velocity in the left anterior descending coronary artery. Baseline characteristics and reduction in systolic and diastolic blood pressure after 6 months were similar in both groups. CFVR in the valsartan group increased from 2.34+/-0.38 to 3.10+/-0.84 at 2 months (p<0.05), and to 3.04+/-1.09 at 6 months (p<0.01). Both values became comparable to that in the control group (2.81+/-0.60). CFVR in the valsartan group was significantly higher (p<0.001) than that in the nifedipine group, which was little changed at 6 months. This discrepancy was derived from the significant increase of hyperemic velocity in the valsartan group, from 36.6+/-17.3 cm/s to 41.1+/-12.7 cm/s at 2 months, and to 48.1+/-20.2 cm/s at 6 months. We concluded that the ARB valsartan not only reduced high blood pressure but improved CFVR in hypertensive patients. However, these effects were not seen with the CCB nifedipine.
Authors:
Fumihiko Kamezaki; Hiromi Tasaki; Kazuhito Yamashita; Kiyoko Shibata; Noriko Hirakawa; Masato Tsutsui; Ryouji Kouzuma; Toshihisa Nagatomo; Tetsuo Adachi; Yutaka Otsuji
Related Documents :
3541597 - Calcium channel blockers in the management of hypertension in the elderly.
9377617 - Coadministration of tamsulosin and three antihypertensive agents in patients with benig...
15089817 - Comparison of once-daily nifedipine controlled-release with twice-daily nifedipine reta...
2069777 - Isolated t-wave abnormalities and evaluation of left ventricular wall motion after nife...
15667797 - Effects of antihypertensives on arterial responses associated with obstructive sleep ap...
18234377 - Antiendothelial cell antibody levels in patients with masked hypertension.
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Hypertension research : official journal of the Japanese Society of Hypertension     Volume:  30     ISSN:  0916-9636     ISO Abbreviation:  Hypertens. Res.     Publication Date:  2007 Aug 
Date Detail:
Created Date:  2007-10-05     Completed Date:  2007-11-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9307690     Medline TA:  Hypertens Res     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  699-706     Citation Subset:  IM    
Affiliation:
The Second Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Angiotensin II Type 1 Receptor Blockers / administration & dosage*
Blood Flow Velocity / drug effects
Blood Pressure / drug effects
Calcium Channel Blockers / administration & dosage*
Coronary Circulation / drug effects*
Echocardiography
Female
Humans
Hyperemia / physiopathology
Hypertension / drug therapy*,  physiopathology
Male
Middle Aged
Nifedipine / administration & dosage*
Tetrazoles / administration & dosage*
Valine / administration & dosage,  analogs & derivatives*
Chemical
Reg. No./Substance:
0/Angiotensin II Type 1 Receptor Blockers; 0/Calcium Channel Blockers; 0/Tetrazoles; 137862-53-4/valsartan; 21829-25-4/Nifedipine; 7004-03-7/Valine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension...
Next Document:  Reproducibility of nocturnal blood pressure assessed by self-measurement of blood pressure at home.